All stories tagged funding-trends on VentureGrill.
New data on Series A hurdles reveals a market where revenue growth is no longer sufficient to secure funding without a clear path to profitability.
Global venture funding into biotech startups has maintained a consistent trajectory, hovering between $36 billion and $40 billion annually, even as AI investment experiences dramatic shifts.
Despite seasonal expectations, July venture activity remained robust as elite funds and corporate strategists accelerated deployment, signaling a deeply bifurcated market.
Global venture funding surged in July, reaching an unprecedented $65 billion and marking a 100% year-over-year increase, driven by a record 14 billion-dollar rounds.
U.S. venture capital investment surged to $412.7 billion in the first half of 2026, a 30% increase over 2025's full year, yet much of this capital is not reaching later-stage startups.